Vol.31 No.1 Contents
 |
Hideyuki Okano Editor in Chief Inflammation and Regeneration Cover [  PDF(660KB)] |
Editorial
| 1．Welcome to the new era of Inflammation and Regeneration |
1 |
|
H. Okano |
|
|
[PDF （126KB）] |
Review Article
| 2．Toward using iPS cells to treat spinal cord injury: Their safety and therapeutic efficacy |
2-10
|
|
K. Miura, O. Tsuji, M. Nakamura, H. Okano
|
|
|
[PDF （315KB）]
|
| 3．Chemokines in inflammatory and immune diseases |
11-24
|
|
K. Matsushima, Y. Terashima, E. Toda, F. Shand, S. Ueha
|
|
|
[PDF （1644KB）]
|
| 4．Treatment trends of rheumatoid arthritis in Japan: Changes toward globalization and its unique innovation |
25-32
|
|
N. Miyasaka
|
|
|
[PDF （595KB）]
|
| 5．Nuclear reprogramming to treat retinal degenerative diseases |
33-49
|
|
F. Osakada
|
|
|
[PDF （687KB）]
|
Special Issue: "Autoinflammation vs Autoimmunity"
| 6．Overview on autoimmunity and autoinflammation |
50-51
|
|
M. Amagai, K. Matsushima
|
|
|
[PDF （227KB）]
|
| 7．Systemic JIA as an Autoinflammatory Disease |
52-65
|
|
S. Takei
|
|
|
[PDF （483KB）]
|
| 8．Sarcoidosis and autoinflammation |
66-71
|
|
N. Kanazawa
|
|
|
[PDF （519KB）]
|
| 9．Autoinflammatory diseases and the inflammasome: Mechanisms of IL-1β activation leading to neutrophil-rich skin disorders |
72-80
|
|
N. Kanbe, T. Satoh, Y. Nakamura, M. Iwasawa, H. Matsue
|
|
|
[PDF （573KB）]
|
| 10．Involvement of inflammation in autoinflammation and autoimmune disease |
81-87
|
|
K. Furuichi, T. Wada, S. Kaneko
|
|
|
[PDF （342KB）]
|
Mini Review
| 11．Activity assay of Lipoamidase, an expected modulator of metabolic fate of externally administered lipoic acid |
88-94
|
|
M. Wang, R. Motafakkerazad, S. Matsugo, N. Wada, T. Konishi
|
|
|
[PDF （398KB）]
|
| 12．Transient receptor potential vanilloid 1 agonists as candidates for anti-inflammatory agents |
95-101
|
|
F. Tsuji, M. Murai, K. Oki, M. Sasano, H. Aono
|
|
|
[PDF （439KB）]
|
| 13．T lymphocyte function in the delayed phase of ischemic brain injury |
102-109
|
|
T. Shichita, G. Muto, A. Yoshimura
|
|
|
[PDF （623KB）]
|
| 14．Human T-lymphotropic virus type 1 (HTLV-1) and innate immunity |
110-115
|
|
T. Sato, K. Azakami, H. Ando, N. Araya, Y. Yamano
|
|
|
[PDF （399KB）]
|
Original Article
| 15．Mesp1+ early paraxial mesodermal cells supply initial bone marrow mesenchymal stem cells capable of differentiating into neural crest lineage cells |
116-124
|
|
K. Niibe, S. Morikawa, Y. Mabuchi, D. Araki, T. Nakagawa, H. Okano, Y. Matsuzaki
|
|
|
[PDF （1286KB）]
|